| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
97,391 |
91,270 |
$11.38M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
90,364 |
85,986 |
$10.37M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
77,275 |
76,274 |
$9.01M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
50,055 |
49,404 |
$5.90M |
| 99051 |
|
99,413 |
93,280 |
$2.14M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
34,774 |
33,184 |
$784K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
51,506 |
49,401 |
$665K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
4,025 |
3,940 |
$435K |
| 99215 |
Prolong outpt/office vis |
3,026 |
2,969 |
$352K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,253 |
2,193 |
$261K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
69,746 |
68,019 |
$181K |
| 99205 |
Prolong outpt/office vis |
1,397 |
1,381 |
$163K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,391 |
2,252 |
$159K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
65,370 |
51,321 |
$98K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
7,321 |
7,207 |
$73K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
13,668 |
13,082 |
$51K |
| 81025 |
|
23,617 |
22,757 |
$48K |
| 71046 |
Radiologic examination, chest; 2 views |
5,242 |
5,140 |
$31K |
| 81003 |
|
33,814 |
32,614 |
$29K |
| 10060 |
|
579 |
572 |
$26K |
| 87808 |
|
6,134 |
5,861 |
$25K |
| 73130 |
|
2,579 |
2,505 |
$17K |
| 73610 |
|
2,972 |
2,907 |
$16K |
| 87905 |
|
7,905 |
7,571 |
$15K |
| 73630 |
|
2,858 |
2,789 |
$15K |
| 93000 |
|
2,204 |
2,170 |
$14K |
| 69209 |
|
1,107 |
1,074 |
$13K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,499 |
3,348 |
$13K |
| 12001 |
|
304 |
300 |
$10K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,626 |
3,550 |
$7K |
| L3809 |
Wrist hand finger orthosis, without joint(s), prefabricated, off-the-shelf, any type |
222 |
222 |
$7K |
| 73110 |
|
1,483 |
1,445 |
$6K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,329 |
1,291 |
$6K |
| L4361 |
Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf |
132 |
130 |
$6K |
| 74018 |
|
842 |
834 |
$5K |
| 90756 |
|
86 |
86 |
$5K |
| 72100 |
|
503 |
492 |
$5K |
| 99201 |
|
53 |
53 |
$5K |
| 73562 |
|
905 |
888 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
7,487 |
7,321 |
$4K |
| 73560 |
|
622 |
598 |
$4K |
| 73030 |
|
765 |
751 |
$3K |
| 73140 |
|
637 |
624 |
$3K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
939 |
920 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,230 |
4,118 |
$2K |
| L4350 |
Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf |
190 |
190 |
$2K |
| 12011 |
|
33 |
33 |
$2K |
| 69200 |
|
31 |
29 |
$2K |
| 73070 |
|
418 |
414 |
$1K |
| 12002 |
|
13 |
13 |
$990.00 |
| 87807 |
|
1,829 |
1,816 |
$910.76 |
| 99024 |
|
46 |
44 |
$840.00 |
| L3908 |
Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf |
145 |
141 |
$801.60 |
| 82962 |
|
1,119 |
1,096 |
$765.40 |
| 29125 |
|
36 |
36 |
$724.75 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
2,087 |
2,019 |
$720.19 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
349 |
344 |
$651.61 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
334 |
330 |
$634.92 |
| 72040 |
|
200 |
198 |
$626.84 |
| Q4049 |
Finger splint, static |
658 |
647 |
$576.55 |
| 73090 |
|
233 |
228 |
$570.61 |
| 73590 |
|
116 |
108 |
$545.83 |
| 36415 |
Collection of venous blood by venipuncture |
165 |
163 |
$480.00 |
| 73660 |
|
66 |
66 |
$459.20 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
382 |
376 |
$384.45 |
| 86308 |
|
802 |
798 |
$383.70 |
| 73502 |
|
79 |
78 |
$346.06 |
| E0114 |
Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips |
902 |
884 |
$345.12 |
| A4565 |
Slings |
363 |
361 |
$345.00 |
| A6449 |
Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard |
1,367 |
1,343 |
$245.00 |
| 29130 |
|
69 |
69 |
$184.07 |
| 81002 |
|
390 |
384 |
$181.74 |
| L3260 |
Surgical boot/shoe, each |
193 |
193 |
$180.00 |
| 71045 |
Radiologic examination, chest; single view |
52 |
52 |
$155.72 |
| 90714 |
|
31 |
31 |
$144.19 |
| 90687 |
|
18 |
17 |
$120.00 |
| 69210 |
|
13 |
13 |
$115.00 |
| 71101 |
|
15 |
14 |
$110.01 |
| 90715 |
|
30 |
30 |
$78.76 |
| 80053 |
Comprehensive metabolic panel |
42 |
42 |
$69.75 |
| 73080 |
|
15 |
15 |
$57.36 |
| 4004F |
|
56 |
52 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
112 |
112 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
26 |
26 |
$0.00 |
| 72070 |
|
33 |
32 |
$0.00 |
| G8484 |
Influenza immunization was not administered, reason not given |
968 |
916 |
$0.00 |
| G8509 |
Pain assessment documented as positive using a standardized tool, follow-up plan not documented, reason not given |
199 |
188 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
276 |
258 |
$0.00 |
| G8421 |
Bmi not documented and no reason is given |
231 |
216 |
$0.00 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
32 |
31 |
$0.00 |
| A6448 |
Light compression bandage, elastic, knitted/woven, width less than three inches, per yard |
54 |
54 |
$0.00 |
| 1036F |
|
231 |
216 |
$0.00 |
| A4467 |
Belt, strap, sleeve, garment, or covering, any type |
87 |
86 |
$0.00 |
| G8422 |
Bmi not documented, documentation the patient is not eligible for bmi calculation |
21 |
21 |
$0.00 |
| G8732 |
No documentation of pain assessment, reason not given |
45 |
43 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
53 |
53 |
$0.00 |
| Q4022 |
Cast supplies, short arm splint, adult (11 years +), fiberglass |
12 |
12 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
22 |
19 |
$0.00 |
| G8432 |
Depression screening not documented, reason not given |
434 |
410 |
$0.00 |